Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer

Details for Australian Patent Application No. 2008229295 (hide)

Owner Globeimmune, Inc.

Inventors Rodell, Timothy C.; Apelian, David; Franzusoff, Alex

Agent FB Rice

Pub. Number AU-A-2008229295

PCT Pub. Number WO2008/115610

Priority 60/910,796 09.04.07 US; 60/895,689 19.03.07 US

Filing date 17 January 2008

Wipo publication date 25 September 2008

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/115610 Priority application(s): WO2008/115610

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008229302-Armor unit

2008229273-MIMO wireless communication method and apparatus for transmitting and decoding resource block structures based on a dedicated reference signal mode